Search

Objective: To evaluate the diagnostic value of an implantable loop recorder (ILR) in dogs with unexplained syncope., Design: Prospective case series., Animals: 12 dogs with recurrent unexplained syncope., Procedures: An ILR was surgically inserted in a pocket created in the subcutaneous tissues of the left hemithorax of each dog. The ILRs were programmed for manual and automatic activation, and event analysis and programming were performed at 3-month intervals and after each syncopal episode., Results: The ILR was manually activated in 7 of 12 dogs at least once within 45 to 218 days (median, 120 days) after implantation. Four dogs had syncopal episodes associated with sinus tachycardia followed by sinus bradycardia and asystolic pauses. Two dogs had ventricular tachycardia, and 1 dog had sinus node dysfunction with prolonged sinus arrest that coincided with loss of consciousness and falling. Four dogs had no additional syncopal episodes after implantation of the ILR. In the remaining dog, the owner was unable to activate the ILR during the only syncopal episode observed for that dog after ILR implantation. In all 12 dogs, analysis of ECG traces after automatic activation of recording revealed normal cardiac rhythms., Conclusions and Clinical Relevance: Data gained after manual activation of an ILR provided valuable diagnostic and prognostic information in almost all dogs with unexplained syncopal episodes by confirming or disproving an association between syncope and arrhythmias. However, detection of disturbances in cardiac rhythm after automatic activation did not appear to improve the diagnostic value for an ILR implanted in dogs.

Objective: To evaluate the effect of 4 antiarrhythmic treatment protocols on number of ventricular premature complexes (VPC), severity of arrhythmia, heart rate (HR), and number of syncopal episodes in Boxers with ventricular tachyarrhythmias., Design: Randomized controlled clinical trial., Animals: 49 Boxers., Procedure: Dogs with > 500 VPC/24 h via 24-hour ambulatory ECG (AECG) were treated with atenolol (n = 11), procainamide (11), sotalol (16), or mexiletine and atenolol (11) for 21 to 28 days. Results of pre- and posttreatment AECG were compared with regard to number of VPC/24 h; maximum, mean, and minimum HR; severity of arrhythmia; and occurrence of syncope., Results: Significant differences between pre- and posttreatment number of VPC, severity of arrhythmia, HR variables, or occurrence of syncope were not observed in dogs treated with atenolol or procainamide. Significant reductions in number of VPC, severity of arrythmia, and maximum and mean HR were observed in dogs treated with mexiletine-atenolol or sotalol; occurrence of syncope was not significantly different between these 2 treatment groups., Conclusions and Clinical Relevance: Treatment with sotalol or mexiletine-atenolol was well tolerated and efficacious. Treatment with procainamide or atenolol was not effective.

Objective: To determine the clinical usefulness of cardiac event recording in evaluating dogs and cats with unexplained syncope, episodic collapse, or intermittent weakness., Design: Retrospective study., Animals: 58 dogs and 2 cats., Procedure: Medical records and electrocardiographic rhythm strips obtained by cardiac event recordings were reviewed. Cardiac rhythm data from the event recordings were classified as diagnostic or nondiagnostic. Diagnostic yield was calculated by dividing the number of animals for which cardiac event recording was diagnostic by the total number of animals undergoing cardiac event recording., Results: For 51 animals, cardiac event recording was classified as diagnostic; therefore, overall diagnostic yield was 85%. Diagnostic yield was lower for animals without underlying structural heart disease (75.5%) than for animals with structural heart disease (95.6%). A specific arrhythmia was identified as the cause of clinical signs in 18 of the 51 (35%) animals for which cardiac event recording was diagnostic. Cardiac arrhythmia was definitively excluded as the cause of clinical signs in the remaining 33 (65%) animals in which cardiac event recording was diagnostic., Conclusions and Clinical Relevance: Results indicate that cardiac event recording had a high diagnostic yield in dogs and cats examined because of unexplained syncope, episodic collapse, or transient weakness and ataxia, regardless of whether animals did or did not have an underlying structural heart disease. Diagnostic yield of cardiac event recording was higher than that reported previously for Holter monitoring.

A permanent, transvenous, atrioventricular, sequential pacing system was implanted successfully in a 7-year-old Quarter Horse gelding with complete heart block. The transvenous atrial and ventricular electrodes were placed in their respective positions in the heart, using real-time, 2-dimensional echocardiography. The horse was able to return successfully to competition as a show horse.